Physicians sort out pros and cons of several new IOLs on the market
2021年11月12日 · Monofocal IOLs The monofocal category was expanded recently with 2 novel aspheric hydrophobic acrylic lenses—the TECNIS Eyhance (ICB00, Johnson + Johnson Vision) and the Clareon (Alcon). The Eyhance IOL has extended depth of focus (EDoF)-like qualities through the design of the central 1 mm of its optic. However, the Eyhance was not approved …
Alcon reveals final data from Vivity Registry Study which …
2023年9月13日 · Alcon has announced final data from its Vivity Registry Study, which monitored real-world patient experiences for up to 12 months post cataract surgery with implantation of either AcrySof IQ Vivity or AcrySof IQ Vivity Toric presbyopia-correcting intraocular lens (PCIOL).
Ophthalmology Times - Ophthalmology news, articles, and events
In a paper presented at the American Academy of Ophthalmology annual meeting in Chicago, Jonathan Tan, a third year medical student at the Icahn School of Medicine at Mount Sinai detailed the study on ophthalmic eye drop waste in clinics, revealing 72% medication loss due to outdated 28-day expiration guidelines, resulting in significant financial waste.
Long-term effects of COVID-19 on the ocular surface
2024年8月16日 · A team of Turkish investigators lead by Oğuzhan Kılıçarslan, FEBO, FICO, MD, reported that COVID-19 affected thecorneal endothelial cell morphology in patients with ocular symptoms. 1 Kılıçarslan is from the Department of Ophthalmology, Ayancık State Hospital, Sinop, Turkey. They conducted a study in which they investigated the long-term effects of the virus on …
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
2023年8月8日 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a …
Dry eye paradise: FDA green-lights Miebo as first and only eye …
2023年6月21日 · In a move that may shift the dry eye treatment paradigm, the FDA recently approved perfluorohexyloctane ophthalmic solution (Miebo; Bausch + Lomb, Novaliq) for the treatment of the signs and symptoms of dry eye disease (DED).. According to the companies, perfluorohexyloctane ophthalmic solution is the first and only FDA-approved treatment for DED …
Identifying, managing dysphotopsia after cataract surgery
2014年4月25日 · Boston — Following cataract surgery, patients can present with a variety of visual complaints-i.e., dysphotopsias, aberrant optical phenomena that interfere with vision after IOL implantation. Positive dysphotopsias include rainbows, streaks, crescents, rings, halos, and veiling glare, haze, and fog. Negative dysphotopsias are relative and absolute scotomas, said …
Study suggests potential link between semaglutide and risk of non ...
2024年7月9日 · Boston researchers led by first author Jimena Tatiana Hathaway, MD, MPH, reported that there is a potential risk of the development of non-arteritic ischemic optic neuropathy (NAION) 1 associated with prescriptions for semaglutide (Wegovy, Ozempic, Novo Nordisk). Prescriptions with semaglutide are FDA approved to treat obesity and type 2 diabetes, …
FDA approves pilocarpine hydrochloride ophthalmic solution for ...
2023年10月18日 · Orasis Pharmaceuticals announces approval of Qlosi, a preservative-free, low-dose eye drop for presbyopia, which consistently demonstrated efficacy, safety, and tolerability in two pivotal Phase 3 trials.
FDA approves eye drops for treatment of presbyopia
2021年10月30日 · Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults.